• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症进展中的新出现突变及其对转录网络的可能影响。

Emerging Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks.

作者信息

Śmiech Magdalena, Leszczyński Paweł, Kono Hidetoshi, Wardell Christopher, Taniguchi Hiroaki

机构信息

Institute of Genetics and Animal Biotechnology, Laboratory for Genome Editing and Transcriptional, Regulation, Polish Academy of Sciences, 05-552 Jastrzębiec, Poland.

Molecular Modeling and Simulation Group, Institute for Quantum Life Science, National Institutes for Quantum and Radiological Science and Technology, Kizugawa, Kyoto 619-0215, Japan.

出版信息

Genes (Basel). 2020 Nov 12;11(11):1342. doi: 10.3390/genes11111342.

DOI:10.3390/genes11111342
PMID:33198372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7697059/
Abstract

Gene mutations can induce cellular alteration and malignant transformation. Development of many types of cancer is associated with mutations in the B-raf proto-oncogene () gene. The encoded protein is a component of the mitogen-activated protein kinases/extracellular signal-regulated kinases (MAPK/ERK) signaling pathway, transmitting information from the outside to the cell nucleus. The main function of the MAPK/ERK pathway is to regulate cell growth, migration, and proliferation. The most common mutations in the gene encode the V600E mutant (class I), which causes continuous activation and signal transduction, regardless of external stimulus. Consequently, cell proliferation and invasion are enhanced in cancer patients with such mutations. The V600E mutation has been linked to melanoma, colorectal cancer, multiple myeloma, and other types of cancers. Importantly, emerging evidence has recently indicated that new types of mutations (classes II and III) also play a paramount role in the development of cancer. In this minireview, we discuss the influence of various BRAF mutations in cancer, including aberrant transcriptional gene regulation in the affected tissues.

摘要

基因突变可诱导细胞改变和恶性转化。多种癌症的发生与B-raf原癌基因()基因的突变有关。编码的蛋白质是丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)信号通路的一个组成部分,将信息从细胞外传递到细胞核。MAPK/ERK通路的主要功能是调节细胞生长、迁移和增殖。该基因最常见的突变编码V600E突变体(I类),无论外部刺激如何,都会导致持续激活和信号转导。因此,患有此类突变的癌症患者的细胞增殖和侵袭会增强。V600E突变与黑色素瘤、结直肠癌、多发性骨髓瘤和其他类型的癌症有关。重要的是,最近新出现的证据表明,新型突变(II类和III类)在癌症发生中也起着至关重要的作用。在这篇小型综述中,我们讨论了各种BRAF突变在癌症中的影响,包括受影响组织中异常的转录基因调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fa/7697059/288487e7fc82/genes-11-01342-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fa/7697059/8fca5167aa74/genes-11-01342-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fa/7697059/b01d44d75ba9/genes-11-01342-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fa/7697059/288487e7fc82/genes-11-01342-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fa/7697059/8fca5167aa74/genes-11-01342-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fa/7697059/b01d44d75ba9/genes-11-01342-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fa/7697059/288487e7fc82/genes-11-01342-g003.jpg

相似文献

1
Emerging Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks.癌症进展中的新出现突变及其对转录网络的可能影响。
Genes (Basel). 2020 Nov 12;11(11):1342. doi: 10.3390/genes11111342.
2
Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression.致癌突变 BRAF V600E 通过改变基因表达改变 THLE-2 肝母细胞瘤细胞的表型行为。
Int J Mol Sci. 2022 Jan 28;23(3):1548. doi: 10.3390/ijms23031548.
3
Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers.BRAF V600E 和非 V600E 突变型肺癌中 MAPK 信号转导的受体酪氨酸激酶调控的独特依赖性。
Oncogene. 2018 Mar;37(13):1775-1787. doi: 10.1038/s41388-017-0035-9. Epub 2018 Jan 19.
4
Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAF expression.全基因组筛选鉴定出与 BRAF 表达诱导的细胞敏感性相关的新基因。
Oncogene. 2020 Jan;39(4):723-738. doi: 10.1038/s41388-019-1022-0. Epub 2019 Sep 23.
5
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.癌症中 BRAF 改变的分类:可操作突变的新合理治疗策略。
Oncogene. 2018 Jun;37(24):3183-3199. doi: 10.1038/s41388-018-0171-x. Epub 2018 Mar 15.
6
Relationships among mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer.结直肠癌患者突变状态、RAS 通路信号分子表达与临床病理特征和预后的关系。
World J Gastroenterol. 2019 Feb 21;25(7):808-823. doi: 10.3748/wjg.v25.i7.808.
7
Co-existence of BRAF V600E Gene Mutation in Tumor and Non-tumoral Surrounding Tissues in Colorectal Cancer.结直肠癌肿瘤组织与非肿瘤周围组织中BRAF V600E基因突变的共存
In Vivo. 2015 Sep-Oct;29(5):577-84.
8
The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.BRAF(V600E)抑制剂PLX4032可增加黑色素瘤细胞中I型胶原蛋白的合成。
Matrix Biol. 2015 Oct;48:66-77. doi: 10.1016/j.matbio.2015.05.007. Epub 2015 May 16.
9
Therapeutic strategies for inhibiting oncogenic BRAF signaling.抑制致癌性BRAF信号传导的治疗策略。
Curr Opin Pharmacol. 2008 Aug;8(4):419-26. doi: 10.1016/j.coph.2008.06.014. Epub 2008 Aug 3.
10
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations.BRAF 突变型结直肠癌中通过 MAPK 通路改变对 RAF 抑制剂联合治疗产生临床获得性耐药
Cancer Discov. 2015 Apr;5(4):358-67. doi: 10.1158/2159-8290.CD-14-1518. Epub 2015 Feb 11.

引用本文的文献

1
Tissue-agnostic biomarkers in solid tumors: current approvals and emerging candidates.实体瘤中的组织非特异性生物标志物:当前获批情况及新兴候选物
Cancer Metastasis Rev. 2025 Jun 27;44(3):58. doi: 10.1007/s10555-025-10274-2.
2
Exploring Brazilian Green Propolis Phytochemicals in the Search for Potential Inhibitors of B-RafE Enzyme: A Theoretical Approach.探索巴西绿蜂胶植物化学物质以寻找B-RafE酶的潜在抑制剂:一种理论方法。
Pharmaceuticals (Basel). 2025 Jun 16;18(6):902. doi: 10.3390/ph18060902.
3
Evidence-based integration of clinicopathological factors with the risk of papillary thyroid carcinoma lateral cervical lymph node metastasis: systematic review and meta-analysis and subgroup study.

本文引用的文献

1
Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer.RAS-RAF 轴中的致癌突变导致 GREB1 表达增加,从而导致结直肠癌中的肿瘤增殖。
Cancer Sci. 2020 Oct;111(10):3540-3549. doi: 10.1111/cas.14558. Epub 2020 Aug 31.
2
Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma.启动子突变及其对甲状腺乳头状癌基因表达谱的影响。
Cancers (Basel). 2020 Jun 17;12(6):1597. doi: 10.3390/cancers12061597.
3
GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
基于证据的临床病理因素与甲状腺乳头状癌侧颈淋巴结转移风险的整合:系统评价、荟萃分析及亚组研究
Gland Surg. 2025 May 30;14(5):912-928. doi: 10.21037/gs-2025-60. Epub 2025 May 27.
4
Mutational Patterns in Colorectal Cancer: Do PDX Models Retain the Heterogeneity of the Original Tumor?结直肠癌中的突变模式:人源肿瘤异种移植模型是否保留了原发肿瘤的异质性?
Int J Mol Sci. 2025 May 26;26(11):5111. doi: 10.3390/ijms26115111.
5
Targeting endothelial growth factor receptor in thyroid cancer: current concepts and future directions.甲状腺癌中内皮生长因子受体的靶向治疗:当前概念与未来方向
Med Oncol. 2025 Jun 2;42(7):233. doi: 10.1007/s12032-025-02788-0.
6
A computed tomography-based radiomics prediction model for BRAF mutation status in colorectal cancer.一种基于计算机断层扫描的结直肠癌BRAF突变状态的影像组学预测模型。
Abdom Radiol (NY). 2025 May 15. doi: 10.1007/s00261-025-04983-z.
7
Mutational Landmarks in Anaplastic Thyroid Cancer: A Perspective of a New Treatment Strategy.间变性甲状腺癌的突变标志物:一种新治疗策略的视角
J Clin Med. 2025 Apr 23;14(9):2898. doi: 10.3390/jcm14092898.
8
Unraveling alterations: molecular insights to circumvent therapeutic resistance across cancer types.揭示改变:跨越癌症类型规避治疗耐药性的分子见解。
Cancer Drug Resist. 2025 Mar 24;8:14. doi: 10.20517/cdr.2024.213. eCollection 2025.
9
Translational Advances in Oncogene and Tumor-Suppressor Gene Research.癌基因与肿瘤抑制基因研究的转化进展
Cancers (Basel). 2025 Mar 17;17(6):1008. doi: 10.3390/cancers17061008.
10
Therapeutic Potential of Species in Gastrointestinal Oncology.物种在胃肠道肿瘤学中的治疗潜力
Cancers (Basel). 2025 Mar 10;17(6):938. doi: 10.3390/cancers17060938.
GADD45B 转录本是接受甲状腺全切除术和放射性碘治疗的甲状腺乳头状癌患者的预后标志物。
Front Endocrinol (Lausanne). 2020 Apr 30;11:269. doi: 10.3389/fendo.2020.00269. eCollection 2020.
4
Current Advances in the Treatment of BRAF-Mutant Melanoma.BRAF 突变型黑色素瘤治疗的当前进展
Cancers (Basel). 2020 Feb 19;12(2):482. doi: 10.3390/cancers12020482.
5
and Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma.并且突变与多发性骨髓瘤患者的长期随访中的不良结局相关。
Clin Cancer Res. 2020 May 15;26(10):2422-2432. doi: 10.1158/1078-0432.CCR-19-1507. Epub 2020 Jan 27.
6
The Role of Nrf2 Activity in Cancer Development and Progression.Nrf2活性在癌症发生发展中的作用。
Cancers (Basel). 2019 Nov 8;11(11):1755. doi: 10.3390/cancers11111755.
7
Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer.调控发育和疾病的转录因子:癌症的阿喀琉斯之踵。
Genes (Basel). 2019 Oct 12;10(10):794. doi: 10.3390/genes10100794.
8
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.自抑制和激活 BRAF-MEK1-14-3-3 复合物的结构。
Nature. 2019 Nov;575(7783):545-550. doi: 10.1038/s41586-019-1660-y. Epub 2019 Oct 3.
9
Sesamin Enhances Nrf2-Mediated Protective Defense against Oxidative Stress and Inflammation in Colitis via AKT and ERK Activation.芝麻素通过激活 AKT 和 ERK 增强 Nrf2 介导的对结肠炎氧化应激和炎症的保护防御作用。
Oxid Med Cell Longev. 2019 Aug 26;2019:2432416. doi: 10.1155/2019/2432416. eCollection 2019.
10
The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients.中国 BRAF 突变型非小细胞肺癌患者 BRAF 突变类型与临床特征的相关性。
J Transl Med. 2019 Aug 30;17(1):298. doi: 10.1186/s12967-019-2036-7.